NCT02034799View on ClinicalTrials.gov

Phase IV Bioseal Study in Brain Tumor Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

256

Participants

Timeline

Start Date

November 1, 2013

Primary Completion Date

August 1, 2014

Study Completion Date

September 1, 2014

Conditions
HemostasisMeningioma Surgery
Interventions
BIOLOGICAL

Bioseal Fibrin Sealant

OTHER

Standard of Care (SoC)

Trial Locations (7)

100048

Clinical Investigation Site #7, Beijing

200040

Clinical Investigation Site #2, Shanghai

300052

Clinical Investigation Site #1, Tianjin

310009

Clinical Investigation Site #4, Hangzhou

410008

Clinical Investigation Site #5, Changsha

450052

Clinical Investigation Site #6, Zhengzhou

610041

Clinical Investigation Site #3, Chengdu

All Listed Sponsors
collaborator

Guangzhou Bioseal Biotechnology Co., Ltd.

INDUSTRY

lead

Ethicon, Inc.

INDUSTRY

NCT02034799 - Phase IV Bioseal Study in Brain Tumor Surgery | Biotech Hunter | Biotech Hunter